Episurf Medical

Episurf Medical (NASDAQ: EPIS B) today announces that the Ministry of Health & Prevention in the United Arab Emirates has issued a classification letter for the company's implant technology Episealer® Patellofemoral System, allowing sales in the United Arab Emirates market. The classification follows after a review process.

"As soon as we got the Episealer® Patellofemoral System clearance in the United States, we started the regulatory work of bringing the technology to other markets. The United Arab Emirates is now the second country that cleared the product for sale, and we are continuing to make progress in the regulatory work in other countries too. It's exciting to be able to help even more people by bringing this product to new markets ", says Pål Ryfors, CEO, Episurf Medical.